Stem Cell Transplant |
27.9% |
Cord Blood Transplant Therapy |
22.7% |
Prophylaxis Against Graft Versus Host Disease |
17.5% |
Bone Marrow Transplant |
13.1% |
Graft Versus Host Disease |
3.6% |
Aplastic Anaemia |
2.7% |
Prophylaxis |
2.2% |
Allogenic Bone Marrow Transplantation Therapy |
2.1% |
Bone Marrow Conditioning Regimen |
1.2% |
Premedication |
1.0% |
Acute Lymphocytic Leukaemia |
1.0% |
Hodgkin's Disease |
1.0% |
Unrelated Donor Bone Marrow Transplantation Therapy |
0.8% |
Lymphoma |
0.7% |
Desmoplastic Small Round Cell Tumour |
0.6% |
Renal Transplant |
0.6% |
Hiv Infection |
0.4% |
Acute Graft Versus Host Disease |
0.3% |
Acute Graft Versus Host Disease In Skin |
0.3% |
Chronic Graft Versus Host Disease |
0.3% |